Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 90

    1.

    Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.

    Cherney DZ, Konvalinka A, Zinman B, Diamandis EP, Soosaipillai A, Reich H, Lorraine J, Lai V, Scholey JW, Miller JA.

    Diabetes Care. 2009 Jan;32(1):91-3. Epub 2008 Oct 22.PMID: 18945921 [PubMed - in process]Related articlesFree article

    2.

    The effect of ruboxistaurin on nephropathy in type 2 diabetes.

    Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW.

    Diabetes Care. 2005 Nov;28(11):2686-90.PMID: 16249540 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The Effect of Direct Renin Inhibition on Renal Hemodynamic Function, Arterial Stiffness and Endothelial Function in Humans with Uncomplicated Type 1 Diabetes Mellitus: A Pilot Study.

    Cherney DZ, Lai V, Scholey JW, Miller JA, Zinman B, Reich HN.

    Diabetes Care. 2009 Nov 4. [Epub ahead of print]PMID: 19889802 [PubMed - as supplied by publisher]Related articles

    4.

    Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.

    Miller JA, Thai K, Scholey JW.

    Diabetes. 2000 Sep;49(9):1585-9.PMID: 10969844 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.

    Cherney DZ, Sochett EB, Miller JA.

    Kidney Int. 2005 Oct;68(4):1722-8.PMID: 16164648 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.

    Cherney DZ, Miller JA, Scholey JW, Bradley TJ, Slorach C, Curtis JR, Dekker MG, Nasrallah R, Hébert RL, Sochett EB.

    Diabetes. 2008 Mar;57(3):688-95. Epub 2007 Dec 14.PMID: 18083781 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.

    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.

    Clin Nephrol. 2003 Nov;60(5):318-26.PMID: 14640237 [PubMed - indexed for MEDLINE]Related articles

    8.

    Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.

    Miller JA, Curtis JR, Sochett EB.

    Diabetes. 2003 Jul;52(7):1806-11.PMID: 12829650 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.

    Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ 3rd, Wolka AM, Vinik AI.

    Diabetes Care. 2007 Apr;30(4):896-902.PMID: 17392551 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.

    Pelikánová T, Pinsker P, Smrcková I, Stribrná L, Dryáková M.

    J Diabetes Complications. 1998 Sep-Oct;12(5):264-72.PMID: 9747643 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

    Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA.

    N Engl J Med. 1991 Jun 6;324(23):1626-32. Erratum in: N Engl J Med 1991 Dec 5;325(23):1666. PMID: 2030719 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans.

    Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA.

    Circ Res. 2002 Jan 11;90(1):107-11.PMID: 11786526 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

    Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE.

    Diabetes Care. 2002 Jun;25(6):1072-7.PMID: 12032117 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

    Kidney Int. 2000 Feb;57(2):590-600.PMID: 10652036 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

    Amann B, Tinzmann R, Angelkort B.

    Diabetes Care. 2003 Aug;26(8):2421-5.PMID: 12882873 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.

    Miller JA.

    J Am Soc Nephrol. 1999 Aug;10(8):1778-85.PMID: 10446946 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.

    Cherney DZ, Scholey JW, Nasrallah R, Dekker MG, Slorach C, Bradley TJ, Hébert RL, Sochett EB, Miller JA.

    Am J Physiol Renal Physiol. 2008 Jun;294(6):F1336-41. Epub 2008 Apr 9.PMID: 18400871 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.

    Kato S, Luyckx VA, Ots M, Lee KW, Ziai F, Troy JL, Brenner BM, MacKenzie HS.

    Kidney Int. 1999 Sep;56(3):1037-48.PMID: 10469372 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy.

    Anderson PW, McGill JB, Tuttle KR.

    Curr Opin Nephrol Hypertens. 2007 Sep;16(5):397-402. Review.PMID: 17693752 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans.

    Komers R, Komersova K, Kazdova L, Ruzickova J, Pelikanova T.

    J Hypertens. 2000 Jan;18(1):51-9.PMID: 10678543 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data